Vitamin B2 detection by mass spectrometry
US-11300559-B2 · Apr 12, 2022 · US
US12196742B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12196742-B2 |
| Application number | US-202318487654-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 16, 2023 |
| Priority date | Dec 18, 2008 |
| Publication date | Jan 14, 2025 |
| Grant date | Jan 14, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods are described for measuring the amount of a vitamin B2 in a sample. More specifically, mass spectrometric methods are described for detecting and quantifying vitamin B2 in a sample utilizing on-line extraction methods coupled with tandem mass spectrometric techniques.
Opening claim text (preview).
What is claimed is: 1. A method for determining the amount of vitamin B2 in a biological sample from a human, said method comprising: purifying the sample by turbulent flow liquid chromatography and high performance liquid chromatography (HPLC); ionizing vitamin B2 to produce one or more ions detectable by tandem mass spectrometry; determining by mass spectrometry the amount of a fragment ion; and determining the amount of vitamin B2 in the sample from the amount of the fragment ion; and wherein the method has a lower limit of quantitation of 5 nmol/L to 25 nmol/L, inclusive. 2. The method of claim 1 , wherein said HPLC and mass spectrometry are conducted with on-line processing. 3. The method of claim 1 , wherein said biological sample comprises plasma or serum. 4. The method of claim 1 , wherein ionizing consists of electrospray ionization (ESI). 5. The method of claim 4 , wherein ESI is in positive ion mode. 6. The method of claim 1 , wherein the HPLC is a reverse-phase high performance liquid chromatography (RP-HPLC). 7. The method of claim 1 , further comprising protein precipitation. 8. The method of claim 7 , wherein an acid is used for precipitating protein. 9. The method of claim 1 , wherein the fragment ion has a mass to charge ratio of 243.2=0.5.
by an electron beam, e.g. electron impact dissociation, electron capture dissociation · CPC title
Methods for using particle spectrometers · CPC title
Liquid chromatography · CPC title
interfaced to liquid or supercritical fluid chromatograph (interfaces in general for introducing or extracting samples to be analysed with specially adapted mass spectrometer, see H01J49/04) · CPC title
Step by step routines describing the use of the apparatus (H01J49/0081 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.